← Open Payments lookup

MEAGAN TAYLOR: Open Payments

NPI 1912678897 · DURANGO, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,991 in 72 payments from 14 companies in 2025. Trend: 2023 $33 · 2024 $1,999 · 2025 $1,991

Food & beverage: $1,991
CompanyPaymentsAmount
ABBVIE INC.24$643
Ardelyx, Inc.9$260
Janssen Biotech, Inc.6$235
Takeda Pharmaceuticals U.S.A., Inc.7$207
Gilead Sciences, Inc.8$173
Madrigal Pharmaceuticals2$149
Salix Pharmaceuticals, a division of Bausch Health US, LLC5$104
GENZYME CORPORATION2$48
Aimmune Therapeutics, Inc.2$46
Lilly USA, LLC2$44

Products named: RINVOQ, IBSRELA, TREMFYA, ENTYVIO, REZDIFFRA, SKYRIZI, XIFAXAN, MAVYRET.

Industry payments across CO — which companies pay providers there.